Wednesday, July 23, 2008
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines
AbstractPurpose To define the most effective combination schedule of paclitaxel and nedaplatin, a new platinum derivative, we investigated the in vitro interaction between these drugs in AZ-521 and NUGC-4 gastric adenocarcinoma and KSE-1 esophageal squamous carcinoma cell lines.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment